Evidence map›Paper›PMID 27994865›Full record

ArticleClinical kidney journal2016

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Joerg Seckinger, Wilfried Dschietzig, Gerd Leimenstoll, Peter M Rob, Martin K Kuhlmann, Wolfgang Pommer, Uwe Fraass, Eberhard Ritz, Vedat Schwenger

Erratum issuedAbstract read
In one paragraph

Article in Clinical kidney journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Impact of Adverse Drug Reactions in Patients with End Stage Renal Disease in Greece.International journal of environmental research and public health · 2020
    Article
  6. Article
  7. Observational
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Joerg SeckingerDivision of Nephrology, Department of Internal Medicine, Zug Cantonal Hospital, Landhausstrasse 11, 6340 Baar, Switzerland.
Wilfried DschietzigNephrologicum Lausitz, Ambulantes Zentrum fuer Nieren- und Hochdruckerkrankungen, Cottbus, Germany.
Gerd LeimenstollNieren- und Gefaesszentrum Kiel, Ambulanz fuer Nieren- und Hochdruckerkrankungen, Dialyse und Transplantationsmedizin, Kiel, Germany.
Peter M RobSana Kliniken Luebeck, Nierenzentrum, Luebeck, Germany.
Martin K KuhlmannDivision of Nephrology, Department of Internal Medicine, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
Wolfgang PommerKfH Kuratorium fuer Dialyse und Nierentransplantation e.V., Bildungszentrum, Neu-Isenburg, Germany.
Uwe FraassAmgen GmbH, Munich, Germany.
Eberhard RitzDivision of Nephrology, Department of Internal Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 162, 69120 Heidelberg, Germany.
Vedat SchwengerDivision of Nephrology, Department of Internal Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 162, 69120 Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe physical-functional and social-emotional health as well as survival of the elderly (≥75 years of age) haemodialysis patient is commonly thought to be poor. In a prospective, multicentre, non-interventional, observational study, the morbidity, mortality and quality of life (QoL) in this patient group were examined and compared with a younger cohort.

methodsIn 92 German dialysis centres, 2507 prevalent patients 19-98 years of age on haemodialysis for a median of 19.2 months were included in a drug monitoring study of darbepoetin alfa. To examine outcome and QoL parameters, 24 months of follow-up data in the age cohorts <75 and ≥75 years were analysed. Treatment parameters, adverse and intercurrent events, hospitalizations, morbidity and mortality were assessed. QoL was evaluated by means of the 47-item Functional Assessment of Chronic Illness Therapy-Anaemia score (FACT-An, version 4).

resultsThe 2-year mortality rate was 34.7% for the older cohort and 15.8% for the younger cohort. The mortality rate for the haemodialysed elderly patients was 6.2% higher in absolute value compared with the age-matched background population. A powerful predictor of survival was the baseline FACT-An score and a close correlation with the 20-item anaemia subscale (AnS) was demonstrated. While the social QoL in the elderly patients was more stable than in the younger cohort (leading to equivalent values at the end of the study period), a pronounced deterioration of physical and functional status was observed. The median number of all-cause hospital days per patient-year was 12.3 for the elderly cohort and 8.9 for the younger patient population. The overall 24-month hospitalization rate was only marginally higher in the elderly cohort (34.0 versus 33.3%).

conclusionsIn this observational study, the mortality rate of elderly haemodialysis patients was not exceedingly high compared with the age-matched background population. Furthermore, the hospitalization rate was only slightly higher compared with the younger age group and the median yearly hospitalization time trended lower compared with registry data. The social well-being of elderly haemodialysis patients showed a less pronounced decline over time and was equal to the score of the younger cohort at the end of the study period. The physical and functional status in the elderly patients was lower and showed a sharper decline over time. The baseline FACT-An score correlated closely with the 24-month survival probability.

Indexed as

chronic haemodialysiselderlyquality of lifesurvival analysisvascular access

Identifiers

PMID27994865
PMCPMC5162412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.